Abstract
The formation of the bipolar spindle is responsible for accurate chromosomal segregation during mitosis. The dynamic instability of microtubules has an important role in this process, and has been shown to be an effective target for cancer chemotherapy. Several agents that target non-microtubule mitotic proteins, including the motor protein Eg5, Aurora kinases and Polo-like kinases, are currently being developed as chemotherapeutic drugs. However, because the efficacies of these drugs remain elusive, new molecular targets that have essential roles in tumor cells are desired. Here, we provide in vivo evidence that transforming acidic coiled-coil-3 (Tacc3) is a potential target for cancer chemotherapy. Using MRI, we showed that Tacc3 loss led to the regression of mouse thymic lymphoma in vivo, which was accompanied by massive apoptosis. By contrast, normal tissues, including the thymus, showed no overt abnormalities, despite high Tacc3 expression. in vitro analysis indicated that Tacc3 depletion induced multi-polar spindle formation, which led to mitotic arrest, followed by apoptosis. Similar responses have been observed in Burkitt's lymphoma and T-ALL. These results show that Tacc3 is a vulnerable component of the spindle assembly in lymphoma cells and is a promising cancer chemotherapy target.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A et al. (2004). The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91: 355–358.
Barr AR, Gergely F . (2008). MCAK-independent functions of ch-Tog/XMAP215 in microtubule plus-end dynamics. Mol Cell Biol 28: 7199–7211.
Bellanger JM, Gonczy P . (2003). TAC-1 and ZYG-9 form a complex that promotes microtubule assembly in C. elegans embryos. Curr Biol 13: 1488–1498.
Charrasse S, Mazel M, Taviaux S, Berta P, Chow T, Larroque C . (1995). Characterization of the cDNA and pattern of expression of a new gene over-expressed in human hepatomas and colonic tumors. Eur J Biochem 234: 406–413.
Cheng J, Haas M . (1990). Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 10: 5502–5509.
Chow VT, Quek HH, Tock EP . (1993). Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line. Cancer Lett 73: 141–148.
Cinti C, Claudio PP, Luca AD, Cuccurese M, Howard CM, D'Esposito M et al. (2000). A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect proapoptotic genes expression in a T-lymphoblastoid drug resistant cell line. Oncogene 19: 5098–5105.
Cullen CF, Ohkura H . (2001). Msps protein is localized to acentrosomal poles to ensure bipolarity of Drosophila meiotic spindles. Nat Cell Biol 3: 637–642.
D'Assoro AB, Lingle WL, Salisbury JL . (2002). Centrosome amplification and the development of cancer. Oncogene 21: 6146–6153.
Farrell PJ, Allan GJ, Shanahan F, Vousden KH, Crook T . (1991). p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J 10: 2879–2887.
Fielding AB, Lim S, Montgomery K, Dobreva I, Dedhar S . (2010). A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells. Oncogene 30: 521–534.
Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW et al. (1991). p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88: 5413–5417.
Gascoigne KE, Taylor SS . (2008). Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14: 111–122.
Gergely F, Draviam VM, Raff JW . (2003). The ch-TOG/XMAP215 protein is essential for spindle pole organization in human somatic cells. Genes Dev 17: 336–341.
Gergely F, Karlsson C, Still I, Cowell J, Kilmartin J, Raff JW . (2000a). The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. Proc Natl Acad Sci USA 97: 14352–14357.
Gergely F, Kidd D, Jeffers K, Wakefield JG, Raff JW . (2000b). D-TACC: a novel centrosomal protein required for normal spindle function in the early Drosophila embryo. EMBO J 19: 241–252.
Harrison MR, Holen KD, Liu G . (2009). Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins. Clin Adv Hematol Oncol 7: 54–64.
Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT et al. (1994). Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1–7.
Jackson JR, Patrick DR, Dar MM, Huang PS . (2007). Targeted antimitotic therapies: can we improve on tubulin agents? Nat Rev Cancer 7: 107–117.
Jacquemier J, Ginestier C, Rougemont J, Bardou VJ, Charafe-Jauffret E, Geneix J et al. (2005). Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Res 65: 767–779.
Janssen K, Pohlmann S, Janicke RU, Schulze-Osthoff K, Fischer U . (2007). Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment. Blood 110: 3662–3672.
Jung CK, Jung JH, Park GS, Lee A, Kang CS, Lee KY . (2006). Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer. Pathol Int 56: 503–509.
Keen N, Taylor S . (2004). Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 4: 927–936.
Kinoshita K, Noetzel TL, Pelletier L, Mechtler K, Drechsel DN, Schwager A et al. (2005). Aurora A phosphorylation of TACC3/maskin is required for centrosome-dependent microtubule assembly in mitosis. J Cell Biol 170: 1047–1055.
Kwon M, Godinho SA, Chandhok NS, Ganem NJ, Azioune A, Thery M et al. (2008). Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev 22: 2189–2203.
Lauffart B, Vaughan MM, Eddy R, Chervinsky D, DiCioccio RA, Black JD et al. (2005). Aberrations of TACC1 and TACC3 are associated with ovarian cancer. BMC Womens Health 5: 8.
Le Bot N, Tsai MC, Andrews RK, Ahringer J . (2003). TAC-1, a regulator of microtubule length in the C elegans embryo. Curr Biol 13: 1499–1505.
Lee MJ, Gergely F, Jeffers K, Peak-Chew SY, Raff JW . (2001). Msps/XMAP215 interacts with the centrosomal protein D-TACC to regulate microtubule behaviour. Nat Cell Biol 3: 643–649.
Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P et al. (2003). Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 100: 5974–5979.
Oliferenko S, Balasubramanian MK . (2002). Astral microtubules monitor metaphase spindle alignment in fission yeast. Nat Cell Biol 4: 816–820.
Peset I, Vernos I . (2008). The TACC proteins: TACC-ling microtubule dynamics and centrosome function. Trends Cell Biol 18: 379–388.
Piekorz RP, Hoffmeyer A, Duntsch CD, McKay C, Nakajima H, Sexl V et al. (2002). The centrosomal protein TACC3 is essential for hematopoietic stem cell function and genetically interfaces with p53-regulated apoptosis. EMBO J 21: 653–664.
Quintyne NJ, Reing JE, Hoffelder DR, Gollin SM, Saunders WS . (2005). Spindle multipolarity is prevented by centrosomal clustering. Science 307: 127–129.
Sato M, Vardy L, Angel Garcia M, Koonrugsa N, Toda T . (2004). Interdependency of fission yeast Alp14/TOG and coiled coil protein Alp7 in microtubule localization and bipolar spindle formation. Mol Biol Cell 15: 1609–1622.
Schmidt S, Schneider L, Essmann F, Cirstea IC, Kuck F, Kletke A et al. (2010). The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program. Oncogene 29: 6184–6192.
Schneider L, Essmann F, Kletke A, Rio P, Hanenberg H, Schulze-Osthoff K et al. (2008). TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF-mediated cell cycle arrest. Oncogene 27: 116–125.
Schneider L, Essmann F, Kletke A, Rio P, Hanenberg H, Wetzel W et al. (2007). The transforming acidic coiled coil 3 protein is essential for spindle-dependent chromosome alignment and mitotic survival. J Biol Chem 282: 29273–29283.
Schuendeln MM, Piekorz RP, Wichmann C, Lee Y, McKinnon PJ, Boyd K et al. (2004). The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer. Mol Cell Biol 24: 6403–6409.
Shamma A, Takegami Y, Miki T, Kitajima S, Noda M, Obara T et al. (2009). Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. Cancer Cell 15: 255–269.
Srayko M, Quintin S, Schwager A, Hyman AA . (2003). Caenorhabditis elegans TAC-1 and ZYG-9 form a complex that is essential for long astral and spindle microtubules. Curr Biol 13: 1506–1511.
Strebhardt K, Ullrich A . (2006). Targeting polo-like kinase 1 for cancer therapy. Nat Rev Cancer 6: 321–330.
Sudakin V, Yen TJ . (2007). Targeting mitosis for anticancer therapy. BioDrugs 21: 225–233.
Tarapore P, Fukasawa K . (2002). Loss of p53 and centrosome hyperamplification. Oncogene 21: 6234–6240.
Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L et al. (2007). Restoration of p53 function leads to tumour regression in vivo. Nature 445: 661–665.
Yao R, Natsume Y, Noda T . (2007). TACC3 is required for the proper mitosis of sclerotome mesenchymal cells during formation of the axial skeleton. Cancer Sci 98: 555–562.
Acknowledgements
We thank T Jacks for providing the R26CreERT2 mice; S Shibata, T Nakahara T Shimomura, S Saito and F Yamagishi for MRI imaging; S Hasegawa for helpful discussions; and Y Terui for the donation of human lymphoma cells. We also thank Y Inoue and T Hirota for critically reading the manuscript. This work was supported by a Grant-in-Aid for cancer research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Yao, R., Natsume, Y., Saiki, Y. et al. Disruption of Tacc3 function leads to in vivo tumor regression. Oncogene 31, 135–148 (2012). https://doi.org/10.1038/onc.2011.235
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.235
Keywords
This article is cited by
-
Suppression of intestinal tumors by targeting the mitotic spindle of intestinal stem cells
Oncogene (2016)
-
A small compound targeting TACC3 revealed its different spatiotemporal contributions for spindle assembly in cancer cells
Oncogene (2014)
-
Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin–proteasome pathway
Cell Death & Disease (2014)
-
Anticancer activity of the Aurora A kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies
Journal of Cancer Research and Clinical Oncology (2014)